nanofibers for peripheral artery disease(Nanotope)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenanofibers for peripheral artery disease(Nanotope)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis stimulants
TargetsUpdating
Therapy Area/IndicationsArtery diseaseMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanotope Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanotope Inc
Active IndicationsN/A
Inactive IndicationsArtery diseaseMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A